Agreement on bases in Syria to serve strengthening of stability in Middle East — MPRussian Politics & Diplomacy January 20, 21:18
Trump's inaugural address: When America is united, America is totally unstoppableWorld January 20, 20:57
Hermitage chief: New Palmyra destruction comes across as militants' vengeanceRussian Politics & Diplomacy January 20, 20:29
Russia's first deputy PM wants to keep current tax system for next political cycleBusiness & Economy January 20, 19:53
Russia’s Shipulin clinches gold in 20km individual race of IBU World Cup stage in ItalySport January 20, 19:18
Prominent Russian adventurer Konyukhov to take samples from Mariana Trench floorSociety & Culture January 20, 19:15
Gazprom CEO says North Stream-2 pipeline proves relevanceBusiness & Economy January 20, 19:10
More survivors found in avalanche-hit Italian hotel — mediaWorld January 20, 18:48
Donald Trump takes office as 45th US PresidentWorld January 20, 18:21
GENEVA, January 14. /TASS/. The number of people killed by the Ebola virus has reached 8,429, the World Health Organization (WHO) said in a report Wednesday.
A total of 21,296 cases of the Ebola virus disease (EVD) have been reported, the statement said.
In line with statistics, the maximum number of Ebola-related deaths and cases has been registered in Liberia - 3,538 cumulative deaths and 8,331 cumulative cases. Liberia is followed by Sierra Leone (3,062 deaths and 10,124 cases) and Guinea (1,814 and 2,806 respectively).
Separate cases have also been registered in Mali, Nigeria, Senegal, Spain, Britain and the United States.
The Ebola virus disease, previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate.
No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.